Krystal Biotech’s Vyjuvek Receives Positive CHMP Opinion for Dystrophic Epidermolysis Bullosa Treatment in the EU In a recent development that holds great significance for the medical community and patients suffering from dystrophic epidermolysis bullosa (DEB), the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion…
Divide, conquer, collaborate: The definitive guide to the modular blockchain stack The Evolution of Traditional Blockchains The following is a guest article from Erick de Moura, co-founder at Cartesi. Despite over a decade of evolution, traditional blockchains continue to grapple with the proverbial ‘blockchain trilemma’, balancing decentralization, security, and scalability. The bigger a blockchain gets…
Investing in the SPDR® S&P Biotech ETF Rising Demand for Biotech Solutions The SPDR® S&P Biotech ETF is a strong investment opportunity in today’s market. With the increasing demand for biotech solutions to address chronic diseases, the biotech industry is poised for significant growth in the coming years. Biotechnology companies are at the forefront of…
Yalla Group Limited Announces Fourth Quarter and Full Year 2024 Financial Results Dubai, UAE, March 4, 2025 – Yalla Group Limited, the leading online social networking and gaming company in the Middle East and North Africa (MENA) region, has announced that it will release its unaudited financial results for the fourth quarter and full year…
Investors Alert: Faruqi & Faruqi, LLP Investigates Potential Claims Against Edwards Lifesciences Corporation Are you an investor who suffered losses exceeding $100,000 in Edwards? If you have experienced losses in Edwards Lifesciences Corporation (“Edwards”) between February 6, 2024 and July 24, 2024, you may have legal options to recover your losses. Faruqi & Faruqi partner…
Welcome to the Financial World of Cerus Corporation Get Ready for the Exciting Updates! Hey there finance enthusiasts! Get your calendars ready because Cerus Corporation (Nasdaq: CERS) has some big news coming your way. Mark your calendars for Thursday, February 20, 2025, because that’s when Cerus Corporation will be unveiling its fourth quarter and full-year…
Hamilton Beach Brands Holding Company Q4 2024 Earnings Conference Call: Insights and Impacts On February 26, 2025, at 4:30 PM ET, Hamilton Beach Brands Holding Company (NYSE:HBB) held its Fourth Quarter 2024 Earnings Conference Call. The call was led by Brendan Frey, Investor Relations, ICR, Scott Tidey, President & Chief Executive Officer, and Sally Cunningham,…
Gilead Sciences Inc. (GILD): A New 52-Week High after a Decade-Long Slumber Gilead Sciences Inc., a leading biopharmaceutical company, recently saw its stock surge to a new 52-week high of $106.69 following the release of its fourth-quarter earnings report for the year 2024. This significant milestone marks a resurgence of investor interest in the company,…
